The U.S. Food and Drug Administration (FDA)

Summary: XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)  Xenpozyme is the first approved medication to treat symptoms that are not related…